DiamiR Announces Participation at 2018 Alzheimer's Association International Conference

Thursday, July 19, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

MONMOUTH JUNCTION, N.J., July 19, 2018 /PRNewswire/ -- DiamiR, a developer of innovative minimally invasive diagnostic tests

for neurodegenerative and other diseases, today announced that it will exhibit at the Alzheimer's Association International Conference to be held in Chicago, IL on July 22-26, 2018.

At

the DiamiR booth, #713 in Hall F1 of McCormick Place, the company staff will meet with the conference attendees to discuss DiamiR's targeted approach to early detection, differential diagnosis, and monitoring of neurodegenerative diseases based on the quantitative analysis of brain-enriched microRNAs circulating in plasma. Dr. Kira Sheinerman, Chief Executive Officer, and Jennifer Seibert, Strategic Development, will provide updates on the ongoing and planned projects and discuss collaborative opportunities.

About Alzheimer's Association International Conference The Alzheimer's Association International Conference (AAIC) is the world's largest gathering of researchers from around the world focused on Alzheimer's and other dementias. As a part of the Alzheimer's Association's research program, AAIC serves as a catalyst for generating new knowledge about dementia and fostering a vital, collegial research community.

About DiamiRDiamiR Biosciences is a privately held molecular diagnostics company focused on developing minimally invasive tests for mild cognitive impairment, Alzheimer's disease, and other conditions. The proprietary technology is based on quantitative analysis of organ-enriched microRNA signatures in plasma and is being developed for early diagnosis, patient stratification, as well as disease progression and treatment monitoring. DiamiR collaborates with leading academic centers, disease foundations, and pharma companies. For more information, please visit the company's website at www.diamirbio.com.

Contact: Kira Sheinerman, PhD, MBACEO917-678-0990ksheinerman@diamirbio.com 

Please Note: This news release contains forward-looking statements regarding future events. These statements are predictions and are subject to risks and uncertainties that could cause the actual events or results to differ materially.

Cision View original content:http://www.prnewswire.com/news-releases/diamir-announces-participation-at-2018-alzheimers-association-international-conference-300683500.html

SOURCE DiamiR



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store